These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 11996827)
1. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Cavalli R; Gasco MR; Chetoni P; Burgalassi S; Saettone MF Int J Pharm; 2002 May; 238(1-2):241-5. PubMed ID: 11996827 [TBL] [Abstract][Full Text] [Related]
2. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits. Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355 [TBL] [Abstract][Full Text] [Related]
3. Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distribution. Bargoni A; Cavalli R; Zara GP; Fundarò A; Caputo O; Gasco MR Pharmacol Res; 2001 May; 43(5):497-502. PubMed ID: 11394943 [TBL] [Abstract][Full Text] [Related]
4. Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I--a pharmacokinetic study. Cavalli R; Zara GP; Caputo O; Bargoni A; Fundarò A; Gasco MR Pharmacol Res; 2000 Dec; 42(6):541-5. PubMed ID: 11058406 [TBL] [Abstract][Full Text] [Related]
5. In vivo efficacy of tobramycin-loaded synthetic calcium phosphate beads in a rabbit model of staphylococcal osteomyelitis. Lulu GA; Karunanidhi A; Mohamad Yusof L; Abba Y; Mohd Fauzi F; Othman F Ann Clin Microbiol Antimicrob; 2018 Dec; 17(1):46. PubMed ID: 30593272 [TBL] [Abstract][Full Text] [Related]
6. In vivo efficacy of humanised intermittent versus continuous ceftazidime in combination with tobramycin in an experimental model of pseudomonal pneumonia. Croisier D; Martha B; Piroth L; Chavanet P Int J Antimicrob Agents; 2008 Dec; 32(6):494-8. PubMed ID: 18804348 [TBL] [Abstract][Full Text] [Related]
7. Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of Acuvue contact lenses. Hehl EM; Beck R; Luthard K; Guthoff R; Drewelow B Eur J Clin Pharmacol; 1999 Jun; 55(4):317-23. PubMed ID: 10424326 [TBL] [Abstract][Full Text] [Related]
9. Ocular pharmacokinetics of tobramycin. A comparative radioimmunoassay and microbiological assay. Desai S Int Ophthalmol; 1993 Aug; 17(4):201-10. PubMed ID: 8112967 [TBL] [Abstract][Full Text] [Related]
10. Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin. Cavalli R; Bargoni A; Podio V; Muntoni E; Zara GP; Gasco MR J Pharm Sci; 2003 May; 92(5):1085-94. PubMed ID: 12712429 [TBL] [Abstract][Full Text] [Related]
11. Impact of pH modification of the empirically used tobramycin ophthalmic solution on MIC90 concentration in tears and aqueous humor of donkeys (Equus asinus). Ibrahim A; Abd-Elrasoul MAA; Sabra MS BMC Vet Res; 2024 May; 20(1):218. PubMed ID: 38778405 [TBL] [Abstract][Full Text] [Related]
12. Part II: Enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops. Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K; Aljuffali IA; Alshamsan A J Biomed Mater Res A; 2013 Jun; 101(6):1828-36. PubMed ID: 23184654 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of the ocular bioavailability of topical tobramycin with use of a collagen shield. Chen CC; Takruri H; Duzman E J Cataract Refract Surg; 1993 Mar; 19(2):242-5. PubMed ID: 8487167 [TBL] [Abstract][Full Text] [Related]
15. Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin. Halwani M; Blomme S; Suntres ZE; Alipour M; Azghani AO; Kumar A; Omri A Int J Pharm; 2008 Jun; 358(1-2):278-84. PubMed ID: 18448284 [TBL] [Abstract][Full Text] [Related]
16. Collagen shield drug delivery: therapeutic concentrations of tobramycin in the rabbit cornea and aqueous humor. Unterman SR; Rootman DS; Hill JM; Parelman JJ; Thompson HW; Kaufman HE J Cataract Refract Surg; 1988 Sep; 14(5):500-4. PubMed ID: 3183930 [TBL] [Abstract][Full Text] [Related]
17. LC-MS/MS method for simultaneous quantification of dexamethasone and tobramycin in rabbit ocular biofluids. Meng T; Kosmider L; Chai G; Moothedathu Raynold AA; Pearcy AC; Qin B; Wang Y; Lu X; Halquist MS; Xu Q J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Apr; 1170():122610. PubMed ID: 33713949 [TBL] [Abstract][Full Text] [Related]
18. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability. Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263 [TBL] [Abstract][Full Text] [Related]
19. Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa. Alipour M; Dorval C; Suntres ZE; Omri A J Pharm Pharmacol; 2011 Aug; 63(8):999-1007. PubMed ID: 21718282 [TBL] [Abstract][Full Text] [Related]
20. Perioperative ofloxacin vs. tobramycin: efficacy in external ocular adnexal sterilization and anterior chamber penetration. Kirsch LS; Jackson WB; Goldstein DA; Discepola MJ Can J Ophthalmol; 1995 Feb; 30(1):11-20. PubMed ID: 7780891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]